Membranous nephropathy secondary to pulmonary tuberculosis

Authors

  • Mohammad Yasin Department of Pulmonology, Ayub Teaching Hospital, Abbottabad, Pakistan
  • Mohsin Khan Department of Pulmonology, Ayub Teaching Hospital, Abbottabad, Pakistan
  • Faiza Khan District Head Quarter Hospital, Abbottabad, Pakistan
  • Niama Khan Ayub Teaching Hospital, Abbottabad, Pakistan

DOI:

https://doi.org/10.47391/JPMA.22020

Keywords:

Glomerulonephritis, pulmonary tuberculosis, Rituximab,, Antituberculosis therapy (ATT).

Abstract

Glomerulonephritis (GN), secondary to tuberculosis, is quite a rare condition. Here we report the case of membranous nephropathy, which completely resolved after the treatment of tuberculosis. A 42-year-old man presented to a nephrologist with burning micturition. His urine routine examination (RE) was suggestive of 2+ protein. His 24-hour urinary protein was 4.2 grams. Renal biopsy revealed membranous nephropathy. His autoimmune, hepatitis B, hepatitis C, and HIV workups were non-conclusive. The nephrologist advised him to take Rituximab. Before the commencement of immunosuppressants, his Interferon-gamma Release Assay (IGRA) was tested which turned positive. He was referred to a pulmonologist for treatment of latent tuberculosis and further workup. His sputum geneXpert detected pulmonary TB. He was treated with anti-tuberculous therapy (ATT), and his proteinuria improved gradually and settled. The patient did not require any immunosuppressants for MN. The initial symptoms of MN secondary to TB are subtle. It is imperative to evaluate the cause of membranous nephropathy before starting an immunosuppressant. GN secondary to TB can be treated successfully with ATT.

Key Words: Glomerulonephritis, Pulmonary tuberculosis, Rituximab, Antituberculosis therapy (ATT).

Published

2026-03-26

How to Cite

Mohammad Yasin, Khan, M., Faiza Khan, & Niama Khan. (2026). Membranous nephropathy secondary to pulmonary tuberculosis. Journal of the Pakistan Medical Association, 76(04), 595–597. https://doi.org/10.47391/JPMA.22020

Issue

Section

CASE REPORT